Industry intelligence on the pharmaceutical psilocybin landscape — regulatory developments, manufacturing science, and market dynamics.
Analysis of the global psilocybin API market — current supply constraints, projected demand from advancing clinical trials, market size estimates, and the emerging competitive landscape for pharmaceutical-grade psilocybin suppliers.
Technical overview of Centrifugal Partition Chromatography (CPC) for pharmaceutical-grade psilocybin purification — how CPC works, advantages over traditional column chromatography, solvent systems, and achieving ≥95% purity at scale.
Comprehensive overview of the global psilocybin clinical trials landscape in 2026 — key Phase 2 and Phase 3 programs, therapeutic indications, regulatory milestones, and implications for API demand and manufacturing.
Practical guide to obtaining controlled substance export permits for psilocybin API — understanding the UN Single Convention framework, ONCB export licensing, import permit requirements, and best practices for compliant international shipment.
A detailed overview of the legal pathway for licensed psilocybin manufacturing in Thailand — from the April 2024 Ministerial Notification to the Form YS-5 narcotics manufacturing license and ONCB export permits.
Comparing the two primary production routes for pharmaceutical-grade psilocybin — natural extraction via CPC purification and total chemical synthesis — across purity, scalability, cost, and regulatory considerations.
An overview of Good Manufacturing Practice requirements specific to psilocybin API production — from facility design and environmental controls to analytical testing, batch documentation, and regulatory audit preparation.
For clinical trial sponsors and CROs, sourcing compliant psilocybin API is one of the most complex procurement challenges in modern drug development. Here's how to navigate it.